Congressional Committee Directs Pentagon Update on Psychedelics or Cannabis Policy

The federal government is finally leaning into the potential of psychedelic medicine, and it is a major win for our veterans. A House committee recently greenlit an amendment requiring the Pentagon to provide a detailed progress report on pilot programs using MDMA and other substances to treat PTSD and traumatic brain injuries. This move, spearheaded by Rep. Morgan Luttrell, ensures that these innovative therapies aren’t just buried in red tape but are actively tracked for effectiveness and expanded access.

Key figures like VA Secretary Doug Collins and Robert F. Kennedy Jr. are pushing for plant-based medicine options, signaling a massive shift in how the government views alternative treatments. For the everyday cannabis community, this matters because it breaks down the long-standing stigma surrounding scheduled substances. As the military validates the healing power of psychedelics like psilocybin and MDMA, it paves the way for broader acceptance and eventual legal access for everyone. It’s a huge step toward a future where personal wellness isn't restricted by outdated regulations.